Advanced Materials Aerospace & defense Agriculture Automation & Process Control Automotive & Transportation Banking & Financial Services Biotechnology Building & Construction Chemicals Cloud Computing Communications Devices and Infrastructure Consumer Goods Country Reports Cyber Security Data Center & Networking Energy Energy Utilities Food & Beverage Global Reports Healthcare Industrial Goods Industry Updates Information and Communications Technology IoT, Bigdata & Digitalization IT & Telecom Medical Devices Mining, Minerals and Metals Networking and Communications Next-Generation Networking Technologies Oil & Gas Outsourcing Services Packaging Pharmaceuticals Regional Reports Semiconductor & Electronics Software & Solutions Technology & Media Travel & Tourism
-
Medical Foods Market
The Medical Foods Market size was valued at USD 24,797.5 Million in 2024 and is anticipated to reach USD 36,442.26 Million by 2032, at a CAGR of 4.93% during the forecast period.
-
Antipsoriatics Market
The Antipsoriatics Market was valued at USD 26 billion in 2024 and is projected to reach USD 56.72 billion by 2032, growing at a CAGR of 10% during the forecast period.
-
Adenovirus Type 4 And Type 7 Vaccine Market
Adenovirus Type 4 and Type 7 Vaccine Market size was valued at USD 1 billion in 2024 and is projected to reach USD 2.28 billion by 2032, growing at a CAGR of 7.3% during the forecast period.
-
Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market
The Irritable Bowel Syndrome (IBS) with Diarrhea Drugs Market size was valued at USD 3,314.33 Million in 2024 and is anticipated to reach USD 5,694.63 Million by 2032, at a CAGR of 7% during the forecast period.
-
Mouth Ulcers Treatment Market
The Mouth Ulcers Treatment Market was valued at USD 1.63 billion in 2024 and is projected to reach USD 2.18 billion by 2032, growing at a CAGR of 3.68% during the forecast period.
-
Gamma Aminobutyric Acid Analogs Market
The Gamma Aminobutyric Acid Analogs Market size was valued at USD 134 million in 2024 and is anticipated to reach USD 213.06 million by 2032, at a CAGR of 5.99% during the forecast period.
-
Congenital Hyperinsulinism Treatment Market
The Congenital Hyperinsulinism Treatment Market size was valued at USD 116 million in 2024 and is anticipated to reach USD 182.49 million by 2032, at a CAGR of 5.8% during the forecast period.
-
Casein Glycomacropeptide Market
The Casein Glycomacropeptide Market size was valued at USD 129 million in 2024 and is anticipated to reach USD 234.8 million by 2032, at a CAGR of 7.8% during the forecast period.
-
Amyotrophic Lateral Sclerosis (ALS) Treatment Market
The Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market is projected to grow from USD 657.0 million in 2024 to an estimated USD 1,019.2 million by 2032, with a compound annual growth rate (CAGR) of 5.66% from 2025 to 2032.
-
Duchenne Muscular Dystrophy Drugs Market
Duchenne Muscular Dystrophy (DMD) Drugs Market size was valued at USD 2.5 billion in 2024 and is anticipated to reach USD 5.07 billion by 2032, growing at a CAGR of 9.26% during the forecast period.
